x min read

Active Stocks in Focus: Tupperware Brands Corporation (NYSE:TUP), Boston Scientific Corporation (NYSE:BSX), Biogen Idec Inc. (NASDAQ:BIIB)

Active Stocks in Focus: Tupperware Brands Corporation (NYSE:TUP), Boston Scientific Corporation (NYSE:BSX), Biogen Idec Inc. (NASDAQ:BIIB)
Written by
Ryan Mitchell
Published on
October 23, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Tupperware Brands Corporation (NYSE:TUP) released that its third quarter earnings of $0.90 a share, excluding non-recurring items, $0.01 lower than the Capital IQ Consensus antipastos of $0.91. The firm reported issues downside outlook for Q4, expects EPS of $1.55-$1.60 as compared to $1.70 Capital IQ Consensus Estimate. On the other consideration, Tupperware Brands Corporation (NYSE:TUP) begun last trade with a price of $69.10 and throughout the trading session climbed at $69.81. The day-trade ended with a decrease of -12.10% to closed at $62.77. The stock is going forward its fifty-two week low with -6.12% and lagging behind from its 52 week high price with -33.70%. TUP last month stock price volatility remained 2.18%.Boston Scientific Corporation (NYSE:BSX) released that its third quarter earnings of $0.20 a share, excluding non-recurring items, in-line with the Capital IQ Consensus anticipates of $0.20. The firm declared that its in-line outlook for fourth quarter. The firm issues in-line outlook for FY14, sees EPS of $0.81-$0.83, excluding non-recurring items, as compared to $0.81 Capital IQ Consensus Estimate. Shares of Boston Scientific Corporation (NYSE:BSX) opened at $12.49 with 1325.71 million outstanding shares and hit to its highest price of $12.65 during the day and finally closed at $12.32 by scoring 2.41%. In the whole session, it traded on volume of 40.32 Million shares, which turned higher than its average volume.Biogen Idec Inc. (NASDAQ:BIIB) declared that its third quarter earnings of $3.80 a share, $0.34 improved than the Capital IQ Consensus anticipates of $3.46; revenues surged 37.4% year/year to $2.51B as compared to the $2.49B consensus. Biogen Idec Inc. (NASDAQ:BIIB) stock hit highest price at $314.95, beginning with a price of $300.00 to the closed at 309.07 by a lose of -5.42% with a day range of $290.85-$314.95. The total market capitalization remained 72.985 Billion, total volume of 7.06 Million shares held in the session was surprisingly higher than its average volume of 1195.45 shares.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You